MENU
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 11.11% to -20 cents per share on May 20

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q1'25
Est.
$-0.20
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.02
The last earnings report on March 17 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 45.51K shares outstanding, the current market capitalization sits at 169.71M.
View a ticker or compare two or three
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com